April 22, 2020: "Mallinckrodt plc, a global biopharmaceutical company announced that the U.S.FDA has accepted for review the company's New Drug Application (NDA) for terlipressin,...
April 22, 2020: "Novartis announced that the US Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to Kymriah® (tisagenlecleucel), for an...
April 22, 2020: "The U.S. Centers for Disease Control and Prevention (CDC) and the United States Department of Agriculture’s (USDA) National Veterinary Services...
April 23, 2020: "Shutting down immunization services in the COVID-19 pandemic risks triggering a resurgence of diseases that can be prevented with safe...
April 21, 2020: "Novartis announced new Mayzent® (siponimod) data in the April supplemental issue of Neurology®, the medical journal of the American Academy of Neurology.
The data...
April 21, 2020:" Bayer announced its Canadian organization Bayer Inc., Mississauga, Ontario, will partner with the Population Health Research Institute (PHRI) is launching a...
April 21, 2020: 'The U.S. Food and Drug Administration authorized the first diagnostic test with a home collection option for COVID-19. Specifically, the FDA re-issued...
Chloroquine or
Hydroxychloroquine
Recommendation: There are insufficient clinical data to recommend either for or against using chloroquine or hydroxychloroquine for the treatment of COVID-19 (AIII).
When chloroquine or hydroxychloroquine is used, clinicians should monitor
the patient for...
April 20,2020: "Five projects from across Oxford University's Medical Sciences Division are amongst twenty-one new studies into the novel coronavirus which have been funded...